Acrux Limited
Description Acrux Limited engages in developing and commercializing a range of patient-preferred pharmaceutical products using its technology to administer proven medicines through the skin. The companys products include Axiron to treat testosterone deficiency in men; Evamist for menopause symptoms; and Recuvyra pain relief for dogs. Its product under registration comprises Estradiol MDTS for menopause symptoms. The company is also developing Luramist for female HSDD; Nestorone MDTS for contraception; Nicotine MDTS for smoking cessation; and NSAIDs for pain and inflammation. It operates in Australia, accessing international pharmaceutical markets through commercial partners. Acrux was founded in 1998 and is headquartered in West Melbourne, Australia. To view the detailed information, you need to SUBSCRIBE with us. |
 |